JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 25, 2007; DOI: 10.1124/jpet.107.121624


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.121624v1
322/1/351    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, A. S
Right arrow Articles by Chung, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, A. S
Right arrow Articles by Chung, K. F.


Received for publication February 20, 2007.
Revised April 23, 2007.
Accepted for publication April 24, 2007.

Attenuation of ozone-induced airway inflammation and hyperresponsiveness by c-Jun NH2 terminal kinase inhibitor, SP600125

Alison S Williams 1, Razao Issa 2, Sum yee Leung 1, Puneeta Nath 1, Gregory D Ferguson 3, Brydon L Bennett 3, Ian M Adcock 1, Kian Fan Chung 4*

1 Imperial College London 2 Imperial College london 3 Celgene 4 Imperial College

* Address correspondence to: E-mail: f.chung{at}imperial.ac.uk

Abstract

Ozone has potent oxidising properties and exposure to ozone causes airway hyperresponsiveness (AHR) and lung inflammation. We determined the importance of c-Jun NH2 terminal kinase (JNK), a member of the mitogen-activated protein kinase pathway (MAPK), in ozone-induced AHR and inflammation. SP600125, a specific JNK inhibitor (30mg/kg) or vehicle, was administered by intraperitoneal injection prior to and following ozone exposure (3ppm for 3hours). SP600125 significantly reduced total cells and neutrophils in bronchoalveolar fluid recovered at 20-24h following exposure and inhibited ozone-induced AHR. Ozone exposure induced activation of JNK in the lung as measured by the expression of phosphorylated-c-Jun, an effect abolished by SP600125. Affymetrix gene-microarray revealed that ozone increased the expression of over 400 genes by more than 2-fold, including interleukin-6 (IL-6), CXCL1 (KC) and CCL2 (MCP-1). SP600125 modulated the expression of a subset 29 ozone-induced genes: IL-6 and CCL2 expression were further increased whilst metallothionein (MT-1), hemopexin and MAP3K6 expression were decreased in SP600125-treated ozone-exposed mice. Changes in mRNA for IL-6, CXCL1 and CCL2 were confirmed by real-time PCR. Ozone also decreased the expression of over 500 genes, with the most potent effect on angiopoietin-1. SP600125 modulated the expression of 15 of these genes, and in particular, SP600125 reversed ozone-induced decrease in expression of the redox sensitive transcription factor, hypoxia-induced factor-1{alpha}. This study highlights an important role for JNK in response to oxidative stress through modulation of specific inflammatory and redox mediators. Inhibition of JNK with small molecule kinase inhibitors may be a means of reducing ozone-induced inflammation and AHR.


Key words: bronchial responsiveness, c-jun NH2 terminal kinase, inflammation, neutrophil, oxidative stress, ozone


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T. Roque, E. Boncoeur, V. Saint-Criq, E. Bonvin, A. Clement, O. Tabary, and J. Jacquot
Proinflammatory Effect of Sodium 4-Phenylbutyrate in {Delta}F508-Cystic Fibrosis Transmembrane Conductance Regulator Lung Epithelial Cells: Involvement of Extracellular Signal-Regulated Protein Kinase 1/2 and c-Jun-NH2-Terminal Kinase Signaling
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. E. Lang, E. S. Williams, J. P. Mizgerd, and S. A. Shore
Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L1013 - L1020.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.